Market Closed -
Xetra
12:35:24 2024-03-18 pm EDT
5-day change
1st Jan Change
26.22
EUR
-0.08%
-0.23%
-22.05%
Bayer Aktiengesellschaft : Notification and public disclosure of transactions by persons
March 04, 2019 at 09:35 am EST
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
04.03.2019 / 15:33
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name
Title: First name:
Colleen A. Last name(s):
Goggins
2. Reason for the notification
a) Position / status
Position:
Member of the administrative or supervisory body
b) Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
b) LEI
4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code
Type:
Share Description:
CUSIP 072730302
b) Nature of the transaction
Purchase in connection with the Supervisory Board members' commitment to buy Bayer AG-Shares.
c) Price(s) and volume(s)
Price(s)
Volume(s) 20.450 USD
58282.5 USD
d) Aggregated information
Price
Aggregated volume 20.4500 USD
58282.5000 USD
e) Date of the transaction
f) Place of the transaction
04.03.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
Language:
English Company:
Bayer Aktiengesellschaft
Kaiser-Wilhelm-Allee 1
51373 Leverkusen
Germany Internet:
www.bayer.com
End of News
DGAP News Service
49313 04.03.2019
Global markets live: Adobe, Ulta Beauty, Intel, Walt Disney, McDonald's...
Mar. 15
Chemical industry sees first signs of recovery after crisis year
Mar. 15
DP
Fitch Cuts Bayer's Rating on Softer FY24 Guidance
Mar. 15
MT
Rating: Fitch lowers Bayer's credit rating
Mar. 14
DP
Bayer: testing an AI tool for agriculture
Mar. 14
CF
Bayer, Microsoft to Test Generative AI System for Agriculture
Mar. 14
MT
Dpa-AFX Overview: COMPANIES from 14.03.2024 - 15:15
Mar. 14
DP
Circles: Bayer considering legal manover for US glyphosate lottery
Mar. 14
DP
Bayer, Aignostics Enter Multi-year Research Partnership to Develop Cancer Target Identification Platform
Mar. 14
MT
Global markets live: Adidas, EON, Sandoz, Bayer, Boeing...
Mar. 13
Bayer Says Decision on Royalties Payment to Brazilian Partners Not Yet Final
Mar. 13
MT
Bayer rejects Brazilian farmers' claim that court finds it liable for $2 bln in royalties
Mar. 12
RE
New claim instrument for climate protection contracts launched
Mar. 12
DP
Berenberg lowers target for Bayer to 30 euros - 'Hold'
Mar. 12
DP
BAYER AG : Berenberg remains Neutral
Mar. 12
ZD
European Equities Close Mixed in Monday Trading; Real Estate, Pharmaceutical Stocks Rise
Mar. 11
MT
Global markets live: 3M Company, Bayer, Apple, Boeing, Nvidia...
Mar. 11
Dpa-AFX Overview: COMPANIES from 11.03.2024 - 15:30
Mar. 11
DP
BAYER AG : DZ Bank gives a Buy rating
Mar. 11
ZD
Dpa-AFX Overview: COMPANIES - The most important news from the weekend
Mar. 10
DP
Bayer makes progress with alternative to weedkiller glyphosate
Mar. 09
DP
Bayer: clinical trials in AMD and DME
Mar. 08
CF
Regeneron Says Results From Phase 3 Trials of Eylea HD Met Their Primary Endpoints; Were Published by The Lancet
Mar. 08
MT
Global markets live: Broadcom, Gap, Costco, DocuSign, Bayer...
Mar. 08
Bayer Garners Support from Major Shareholder for Decision to Delay Review of Breakup
Mar. 07
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (49.6%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (37.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (4.9%), Switzerland (1.2%), Europe/Middle East/Africa (22.4%), the United States (30.9%), North America (3.7%), China (8.4%), Asia/Pacific (10.2%), Brazil (10.5%) and Latin America (7.8%).
More about the company
Last Close Price
26.22
EUR
Average target price
39.1
EUR
Spread / Average Target
+49.13%
Consensus
1st Jan change
Capi.
-22.05% 28.06B +30.83% 679B +30.96% 589B +0.01% 381B +15.18% 314B +11.39% 308B +0.78% 212B -6.09% 210B -2.92% 203B -3.72% 158B
Other Pharmaceuticals
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1